(Q44830422)

6 December 2017

title

I.V. busulfan in pediatrics: a novel dosing to improve safety/efficacy for hematopoietic progenitor cell transplantation recipients (English)

1 reference

6 December 2017

Nguyen L

1

1 reference

6 December 2017

Fuller D

2

1 reference

6 December 2017

Lennon S

3

1 reference

6 December 2017

Leger F

4

1 reference

6 December 2017

Puozzo C

5

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

Bone Marrow Transplantation

6 December 2017

published in

1 reference

6 December 2017

volume

33

1 reference

6 December 2017

issue

10

1 reference

6 December 2017

page(s)

979-987

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704446

6 December 2017

exact match

0 references

cites work

Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704446

Individualizing high-dose oral busulfan: prospective dose adjustment in a pediatric population undergoing allogeneic stem cell transplantation for advanced hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704446

Therapeutic monitoring of busulfan in pediatric bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704446

Cellular target of cyclophosphamide toxicity in the murine liver: role of glutathione and site of metabolic activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704446

Target dose adjustment of busulfan in pediatric patients undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704446

Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704446

Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704446

A size standard for pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704446

A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704446

Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704446

Intravenous busulphan for conditioning before autologous or allogeneic human blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704446

A phase II trial of liposomal busulphan as an intravenous myeloablative agent prior to stem cell transplantation: 500 mg/m(2) as a optimal total dose for conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704446

Body surface area estimation in children using weight alone: application in paediatric oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704446

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704446

Methods for measurement of body surface area

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704446

Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704446

Surface area estimation: pocket calculator v nomogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704446

Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704446

7 January 2021

Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704446

7 January 2021

An improved limited sampling method for individualised busulphan dosing in bone marrow transplantation in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704446

7 January 2021

Therapeutic monitoring of busulfan in hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704446

7 January 2021

Disposition of high-dose busulfan in pediatric patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704446

7 January 2021

Determination of human body surface area from height and weight

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704446

7 January 2021

Retrospective appraisal of busulfan dose adjustment in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704446

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704446

1 reference

6 December 2017

1 reference